Literature DB >> 4225185

[Teratogenic action in the rat of an inhibitor of cholesterol synthesis, AY 9944].

C Roux, M Aubry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4225185

Source DB:  PubMed          Journal:  C R Seances Soc Biol Fil        ISSN： 0037-9026


× No keyword cloud information.
  9 in total

Review 1.  The Smith-Lemli-Opitz syndrome.

Authors:  R I Kelley; R C Hennekam
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

2.  Retinal structure and function in an animal model that replicates the biochemical hallmarks of desmosterolosis.

Authors:  S J Fliesler; M J Richards; C Miller; N S Peachey; R J Cenedella
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

3.  Developmental toxicity of haloxyfop ethoxyethyl ester in the rat.

Authors:  K Machera
Journal:  Bull Environ Contam Toxicol       Date:  1993-10       Impact factor: 2.151

4.  Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats.

Authors:  G Xu; G Salen; S Shefer; G C Ness; T S Chen; Z Zhao; G S Tint
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

5.  Abnormal sterol metabolism in holoprosencephaly: studies in cultured lymphoblasts.

Authors:  D Haas; J Morgenthaler; F Lacbawan; B Long; H Runz; S F Garbade; J Zschocke; R I Kelley; J G Okun; G F Hoffmann; M Muenke
Journal:  J Med Genet       Date:  2007-01-19       Impact factor: 6.318

6.  Detection of defective 3 beta-hydroxysterol delta 7-reductase activity in cultured human fibroblasts: a method for the diagnosis of Smith-Lemli-Opitz syndrome.

Authors:  E Lund; L Starck; N Venizelos
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

7.  MRI and 1H MRS findings in Smith-Lemli-Opitz syndrome.

Authors:  P A Caruso; T Y Poussaint; A A Tzika; D Zurakowski; L G Astrakas; E R Elias; C Bay; M B Irons
Journal:  Neuroradiology       Date:  2003-11-05       Impact factor: 2.804

8.  Restoration of immune response by a cationic amphiphilic drug (AY 9944) in vitro: a new approach To chemotherapy against human immunodeficiency virus type 1.

Authors:  A Achour; J C Landureau; R Salerno-Goncalves; R Salerno-Concalves; J C Mazière; D Zagury
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

Review 9.  Abnormal sterol metabolism in holoprosencephaly.

Authors:  Dorothea Haas; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.